Sanxiang Advanced Materials Co., Ltd. (603663.SS)
Ningde, CN
Sanxiang Advanced Materials Co., Ltd. is primarily engaged in the production and global distribution of fundamental materials, including fused zirconia, various cast modification agents, and single crystal fused aluminum. Their extensive zirconia product lineup encompasses stable forms based on yttrium, calcium, magnesium, aluminum, and composite blends. Furthermore, they supply specialized zirconia tailored for diverse applications such as ceramic pigments, refractory materials, high-purity requirements, and other unique industrial uses. Beyond zirconia, the company provides a comprehensive selection of critical casting consumables. These offerings include various cored wires, such as nodulized, nucleated, vermiculated, and calcium-silicon types. They also manufacture heavy rare-earth nodulizers that utilize rare earth and yttrium, alongside a broad spectrum of inoculants. The inoculant range comprises silicon barium, silicon strontium, silicon zirconium, high-aluminum cubic ferrosilicon, long-acting, and special-effect variants, in addition to inoculant chips. Silica fumes are also a part of their product portfolio. These advanced materials find widespread application across numerous high-tech and industrial sectors. Key uses span aerospace, military-grade refractory and abrasive products, ceramic and glaze manufacturing, nuclear-grade zirconia materials, advanced ceramics, casting processes, and high-end abrasive tools. The company maintains a significant global footprint, with operations extending beyond China to numerous international markets. Its presence includes countries such as the United States, Brazil, Mexico, France, Germany, Italy, Spain, Turkey, Holland, Australia, Japan, South Korea, Iran, India, Thailand, Vietnam, Malaysia, Singapore, and Taiwan. Established in 1991, Sanxiang Advanced Materials Co., Ltd. is headquartered in Ningde, China. The company previously operated under the name Fujian Sanxiang Advanced Materials Co., Ltd. until it officially adopted its current designation in March 2012.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.58% | +11.08% | +27.01% | +23.08% | +87.19% | +66.53% | +157.75% | +488.11% | +681.81% | +2,025.27% | +2,025.27% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+10.6% ★ Q1'26: +14.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+55.6% ★ Q1'26: +200.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+7.2% Q1'26: +15.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.9% ★ Q1'26: +19.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.3% ★ Q1'26: +11.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.3% ★ Q1'26: -9.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.84× Q1'26: 1.18× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
277.67M
est: 289.00M (-3.9%)
|
407.85M
est: 289.00M (+41.1%)
|
598.53M
est: 431.00M (+38.9%)
|
761.08M
est: 486.00M (+56.6%)
|
733.11M
est: 553.00M (+32.6%)
|
789.21M
est: 1.00B (-21.1%)
|
972.31M
est: 1.19B (-18.4%)
|
1.08B
est: 1.30B (-17.0%)
|
1.05B
est: 1.37B (-23.2%)
|
1.17B
est: 1.30B (-10.1%)
|
1.85B
1.85B – 1.85B
+42.7% YoY
|
2.35B
2.35B – 2.35B
+26.8% YoY
|
| EBITDA |
53.48M
est: 54.45M (-1.8%)
|
72.11M
est: 54.45M (+32.4%)
|
94.78M
est: 81.21M (+16.7%)
|
168.19M
est: 91.57M (+83.7%)
|
134.40M
est: 104.19M (+29.0%)
|
180.80M
est: 188.41M (-4.0%)
|
240.58M
est: 224.40M (+7.2%)
|
150.68M
est: 245.12M (-38.5%)
|
150.36M
est: 260.72M (-42.3%)
|
222.31M
est: 246.20M (-9.7%)
|
351.30M
351.30M – 351.30M
+42.7% YoY
|
445.30M
445.30M – 445.30M
+26.8% YoY
|
| EBIT |
42.69M
est: 39.02M (+9.4%)
|
61.65M
est: 39.02M (+58.0%)
|
81.46M
est: 58.19M (+40.0%)
|
138.10M
est: 65.62M (+110.5%)
|
97.60M
est: 74.66M (+30.7%)
|
135.51M
est: 135.01M (+0.4%)
|
195.96M
est: 160.80M (+21.9%)
|
97.22M
est: 175.65M (-44.7%)
|
82.90M
est: 184.24M (-55.0%)
|
150.37M
est: 173.98M (-13.6%)
|
248.25M
248.25M – 248.25M
+42.7% YoY
|
314.67M
314.67M – 314.67M
+26.8% YoY
|
| Net Income |
39.33M
est: 42.95M (-8.4%)
|
54.01M
est: 42.95M (+25.7%)
|
74.18M
est: 70.56M (+5.1%)
|
82.71M
est: 81.30M (+1.7%)
|
64.84M
est: 98.17M (-34.0%)
|
100.49M
est: 92.34M (+8.8%)
|
150.87M
est: 180.39M (-16.4%)
|
79.23M
est: 126.27M (-37.3%)
|
75.76M
est: 155.33M (-51.2%)
|
117.55M
est: 132.24M (-11.1%)
|
398.83M
398.83M – 398.83M
+201.6% YoY
|
583.55M
583.55M – 583.55M
+46.3% YoY
|
| SGA |
44.69M
est: 22.73M (+96.6%)
|
36.67M
est: 22.73M (+61.3%)
|
55.02M
est: 33.90M (+62.3%)
|
70.60M
est: 38.22M (+84.7%)
|
65.00M
est: 43.49M (+49.5%)
|
67.34M
est: 78.65M (-14.4%)
|
70.46M
est: 93.67M (-24.8%)
|
76.84M
est: 102.32M (-24.9%)
|
79.69M
est: 92.68M (-14.0%)
|
38.41M
est: 87.52M (-56.1%)
|
124.88M
124.88M – 124.88M
+42.7% YoY
|
158.30M
158.30M – 158.30M
+26.8% YoY
|
| EPS |
0.12
est: 0.10 (+17.6%)
|
0.15
est: 0.10 (+42.9%)
|
0.20
est: 0.17 (+19.3%)
|
0.22
est: 0.19 (+16.2%)
|
0.17
est: 0.23 (-25.6%)
|
0.26
est: 0.22 (+18.5%)
|
0.36
est: 0.43 (-16.0%)
|
0.19
est: 0.30 (-36.7%)
|
0.18
est: 0.37 (-51.4%)
|
0.28
est: 0.32 (-11.1%)
|
0.95
0.95 – 0.95
+201.6% YoY
|
1.39
1.39 – 1.39
+46.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck Rare Earth and Strategic Metals UCITS ETF REMX.L | 2.78% | 36.33M | 0.59% |
| 2 | VanEck Rare Earth and Strategic Metals ETF REMX | 2.77% | 66.49M | 0.53% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chun Qiao Wu | Chairman of Supervisory Board & Head of First Marketing Department | — | male |
| Hai Xia Liu | Accounting Supervisor | — | female |
| Hui Yang | Executive Vice President & Director | — | male |
| Huibin Li | Deputy General Manager | — | male |
| Peng Xia | Chairman & Legal Representative | — | male |
| Ruiqi Xia | General Manager | — | male |
| Shun Qin Fan | Chief Financial Officer | — | female |
| Xiong Zheng | Deputy GM & Secretary of Board of Directors | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603663.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
